Companies
AquaBounty Technologies
its AquAdvantage GE salmon — the first genetically engineered food animal, FDA-approved in 2015 — was rejected by 80+ retailers (Walmart, Costco, Sodexo, Aramark) and AquaBounty shut its last farm (Bay Fortune, PEI) in December 2024; Q1 2026 net loss $1.2M on $441k cash,…
- Country
- United States
- Ticker
- NASDAQ:AQB
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $1.15 million gross proceeds from equity transaction on February 11, 2026 | sec.gov · stocktitan.net |
| Capacity | 10,000 metric ton capacity planned for Ohio farm (construction halted) | sec.gov · stocktitan.net |
| Regulatory approval | FDA approved in 2015; Health Canada approved in 2016; National Biosafety Technical Commission (Brazil) approved in 2021 | dirt-to-dinner.com · investors.aquabounty.com · fda.gov |
| Production site | Company exited all salmon farming operations; Indiana and Canadian farms sold; Ohio facility construction paused and for sale | foe.org · sec.gov · stocktitan.net |
| Headcount | 3 employees as of March 27, 2026 | sec.gov · stocktitan.net |
| Revenue | $6 thousand in sales and marketing for the year 2025 | landbasedaq.com · sec.gov |
Independent sources: dirt-to-dinner.com · fda.gov · foe.org · landbasedaq.com · sec.gov · stocktitan.net
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aquaculture & fish farming | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.